Data from Eloxx’s proof-of-concept trial in patients with nonsense mutation Alport Syndrome (NMAS) presented in...
First two subjects dosed in Phase 1 clinical trial of ZKN-013; ZKN-013 is being developed for the potential...
Almirall obtains exclusive global rights to develop and commercialize ZKN-013 for the treatment of rare...
VANCOUVER, Wash. and BARCELONA, Spain, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a...
VANCOUVER, British Columbia, March 21, 2022 (GLOBE NEWSWIRE) -- Alliance Mining Corp. (TSXV:ALM) announced...
Klisyri has been approved for the treatment of actinic keratosis by the UK Medicines and Healthcare products...
REDWOOD CITY, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG), a pioneer in...
L'OCRCVM permet la reprise de la négociation - ALM; RHC Canada NewsWire VANCOUVER, le 17 oct. 2018 VANCOUVER, le 17 oct. 2018 /CNW/...
IIROC Trading Resumption - ALM; RHC Canada NewsWire VANCOUVER, Oct. 17, 2018 VANCOUVER, Oct. 17, 2018 /CNW/ - Trading resumes in: Company:...
Suspension de la négociation par l'OCRCVM - ALM Canada NewsWire VANCOUVER, le 15 oct. 2018 VANCOUVER, le 15 oct. 2018 /CNW/ - L'OCRCVM a...
IIROC Trading Halt - ALM Canada NewsWire VANCOUVER, Oct. 15, 2018 VANCOUVER, Oct. 15, 2018 /CNW/ - The following issues have been halted by...
L'OCRCVM permet la reprise de la négociation - ALM Canada NewsWire VANCOUVER, le 24 août 2018 VANCOUVER, le 24 août 2018 /CNW/...
IIROC Trading Resumption - ALM Canada NewsWire VANCOUVER, Aug. 24, 2018 VANCOUVER, Aug. 24, 2018 /CNW/ - Trading resumes in: Company: Alliance...
Suspension de la négociation par l'OCRCVM - ALM Canada NewsWire VANCOUVER, le 23 août 2018 VANCOUVER, le 23 août 2018 /CNW/ - L'OCRCVM...
IIROC Trading Halt - ALM Canada NewsWire VANCOUVER, Aug. 23, 2018 VANCOUVER, Aug. 23, 2018 /CNW/ - The following issues have been halted by...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads